Allogenic Adipose-Derived Mesenchymal Stem Cells

· Wuxi Cellular Biopharmaceutical Group Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allogenic Adipose-Derived Mesenchymal Stem Cells, covering 2021-06-30 to 2025-07-16. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis [Phase 3]